Last updated: August 15, 2022
Sponsor: Mohamed Abdelmoneim El Meligy
Overall Status: Active - Recruiting
Phase
N/A
Condition
Joint Injuries
Rheumatoid Arthritis
Rheumatoid Arthritis (Pediatric)
Treatment
N/AClinical Study ID
NCT05504382
P.T.REC/012/003788
Ages 14-16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- • Age ranges from 14 to 16 years.
- All children will be assigned to the study are suffering from persistentoligoarthritis.
- All children have regional knee pain complaint more than 6 weeks.
- Pain and stiffness especially in the morning, and a joint that feels warm to thetouch
- Low grade fever at the onset of disease
Exclusion
Exclusion Criteria:
- • Neurological disorders.
- Dermatological disorders.
- Acute trauma prior to the study.
- Other co- morbidities like diabetes and conditions associated with inflammationsuch as malegnancies.
- Analgesic drugs or NSAIDs during the treatment period.
Study Design
Total Participants: 42
Study Start date:
August 01, 2022
Estimated Completion Date:
May 01, 2023
Study Description
Connect with a study center
Cairo University
Cairo, 12613
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.